<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been reported that antiphospholipid autoantibodies do not recognize <z:chebi fb="0" ids="16247">phospholipid</z:chebi> alone, but rather the plasma protein beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta 2GPI), or a beta 2GPI-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> complex </plain></SENT>
<SENT sid="1" pm="."><plain>In vitro beta 2GPI binds to anionic <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and inhibits the prothrombinase activity of procoagulant membranes </plain></SENT>
<SENT sid="2" pm="."><plain>In light of the fact that <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, a type of <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo>, have similar <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> properties, the relationship of beta 2GPI to <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity was investigated </plain></SENT>
<SENT sid="3" pm="."><plain>IgG from patients with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> or <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> were tested for anticardiolipin reactivity and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity in the presence and absence of beta 2GPI </plain></SENT>
<SENT sid="4" pm="."><plain>As expected, anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> reactivity associated with <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> was beta 2GPI dependent </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, IgG from a patient with <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> recognized <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> alone and binding was inhibited by beta 2GPI </plain></SENT>
<SENT sid="6" pm="."><plain>Autoimmune <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> prolonged the dilute Russell viper venom time of <z:mpath ids='MPATH_458'>normal</z:mpath> plasma, but had no effect on beta 2GPI-depleted plasma </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> associated with <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> had no <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effect </plain></SENT>
<SENT sid="8" pm="."><plain>RP-1, an anti-beta 2GPI mAb, had <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effects similar to those of autoimmune <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>These data demonstrate that antiphospholipid autoantibodies exert <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity via an interaction with beta 2GPI </plain></SENT>
<SENT sid="10" pm="."><plain>These antibodies and RP-1 appear to amplify the <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> effect of beta 2GPI itself </plain></SENT>
</text></document>